Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation

Hawkins, 1992, Quantitating tumor glucose metabolism with FDG and PET, J Nucl Med, 33, 339 Ishizu, 1994, Effects of hyperglycaemia on FDG uptake in human brain glioma, J Nucl Med, 35, 1104 Kostagoglu L, Wong J, Barrington S, et al: Visualisation of laryngeal muscles using 18F fluoro-2-deoxyglucose: A possible cause of false positive PET scan. J Nucl Med (in press) Barrington, 1996, Skeletal muscle uptake of Fluorine-18-FDG: Effect of oral diazepam, J Nucl Med, 37, 1127 Jabour, 1993, Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation, Radiology, 186, 27, 10.1148/radiology.186.1.8416578 Bischof Delalove, 1995, How high a level of FDG abdominal activity is considered normal?, J Nucl Med, 36, 106P Knopp, 1994, Evaluation of pulmonary lesions with positron emission tomography, Radiology, 34, 588 Lewis, 1994, Uptake of fluorine-18-fluorode-oxyglucose in sarcoidosis, J Nucl Med, 35, 1 Hanson, 1995, Diagnostic accuracy of F-18 FDG whole body PET imaging in oncologic patients, J Nucl Med, 36, 193P Cook, 1996, Pagets disease of bone: Appearances with 18-FDG PET, J Nucl Med, 37, 27P Kubota, 1995, Methionine uptake by tumour tissue: A microautoradiographic comparison with FDG, J Nucl Med, 36, 484 Miyauchi, 1995, Does regional FDG uptake vary in normal lung?, J Nucl Med, 36, 4P